new drug for HIV, Ziagen (abacavir)

Glaxo will soon promote a new drug for HIV, Ziagen (abacavir).

It's a potent nucleoside the same class as Retrovir (zidovudine) or 3TC (lamivudine).

It'll be used in combo therapy with other antiretrovirals.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote